Aug 22, 2023 06:49 PM
PODCAST
China Stories: Brand-Name Drugs Feel the Squeeze in China’s Generic-Heavy Market
Aug.22.2023
Multinational pharmaceutical firms are changing strategies and selling business lines, as a government bulk-buying program favors cheaper, local products
00:00/00:00
Note: This is an audio narration of a Caixin Global article first published on June 2, 2023.
Contact reporter Zhang Yukun (yukunzhang@caixin.com)
Download our app to receive breaking news alerts and read the news on the go.
Share this article
Open WeChat and scan the QR code
MORE WAYS TO LISTEN
MOST POPULAR
- 1Finance Movers and Shakers: Former Securities Watchdog Chief Yi Huiman Under Graft Probe
- 2Hong Kong Moves to Ease Capital Rules for Banks Holding Licensed Crypto
- 3AI Offers Hope for Growth, but Global ‘Disorder’ Poses Major Risks, Lawrence Summers Says
- 4China’s Regulator Ramps Up Push to Curb Food Delivery Subsidy War
- 5China, U.S. to Meet in Spain Over TikTok, Trade Disputes
SPONSORED
- 1Power To The People: Pintec Serves A Booming Consumer Class
- 2Largest hotel group in Europe accepts UnionPay
- 3UnionPay mobile QuickPass debuts in Hong Kong
- 4UnionPay International launches premium catering privilege U Dining Collection
- 5UnionPay International’s U Plan has covered over 1600 stores overseas